N
NKGen Biotech Inc
NASDAQ:NKGN
NKGen Biotech Inc
NASDAQ:NKGN
Price:
0.2
USD
185.71%
Market Cap:
$26.1m
Income Statement
Earnings Waterfall
NKGen Biotech Inc
NKGen Biotech Inc
Income Statement
NKGen Biotech Inc
NKGen Biotech Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
1
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
2
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(14)
|
(21)
|
(30)
|
(36)
|
(31)
|
(31)
|
(27)
|
(12)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(7)
|
(9)
|
(14)
|
(18)
|
(17)
|
(18)
|
(16)
|
(15)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(16)
|
(11)
|
(14)
|
(13)
|
(11)
|
(9)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
0
|
(8)
|
0
|
0
|
0
|
12
|
|
| Operating Income |
(3)
N/A
|
(3)
-27%
|
(4)
-22%
|
(4)
+10%
|
(3)
+22%
|
(3)
-8%
|
(14)
-388%
|
(21)
-45%
|
(30)
-42%
|
(36)
-22%
|
(31)
+14%
|
(31)
+0%
|
(27)
+14%
|
(12)
+57%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
6
|
8
|
10
|
6
|
8
|
7
|
3
|
(23)
|
(49)
|
(48)
|
(65)
|
(44)
|
(29)
|
(28)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(4)
|
(4)
|
7
|
27
|
12
|
0
|
|
| Total Other Income |
(4)
|
(4)
|
0
|
0
|
0
|
(4)
|
(6)
|
(5)
|
0
|
(1)
|
2
|
(0)
|
(0)
|
16
|
|
| Pre-Tax Income |
(1)
N/A
|
1
N/A
|
6
+505%
|
3
-58%
|
5
+87%
|
0
-99%
|
(18)
N/A
|
(52)
-192%
|
(83)
-59%
|
(89)
-7%
|
(88)
+1%
|
(48)
+45%
|
(44)
+9%
|
(24)
+47%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(1)
|
1
|
6
|
3
|
5
|
(1)
|
(18)
|
(52)
|
(83)
|
(89)
|
(88)
|
(48)
|
(44)
|
(24)
|
|
| Net Income (Common) |
(1)
N/A
|
1
N/A
|
6
+507%
|
3
-60%
|
5
+81%
|
(1)
N/A
|
(18)
-2 216%
|
(52)
-186%
|
(83)
-58%
|
(89)
-7%
|
(88)
+1%
|
(48)
+45%
|
(44)
+9%
|
(24)
+47%
|
|
| EPS (Diluted) |
-0.07
N/A
|
0.04
N/A
|
0.28
+600%
|
0.1
-64%
|
0.21
+110%
|
-0.04
N/A
|
-3.36
-8 300%
|
-3.9
-16%
|
-3.64
+7%
|
-4.04
-11%
|
-3.65
+10%
|
-1.17
+68%
|
-1.1
+6%
|
-0.22
+80%
|
|
Switch to:
Switch to:
See Also
Discover More
